Cue Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cue Biopharma Inc
TickerCUE
CIK #0001645460
CUSIP22978P106
SectorLife Sciences - Pharmaceutical Preparations
Address675 W Kendall Street, Cambridge, MA 02142
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Cue Biopharma Inc 2022-11-21 30.0 M Exemption: 506(b) · Duration: One year or less · Commission: $1,800,000 · Revenue: Decline to Disclose
Imagen Biopharma Inc 2015-06-19 10.0 M Exemption: 506(b) · Duration: One year or less · Commission: $1,000,000 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001645460] 10-K
[0001645460] 10-Q
[0001645460] 3
[0001645460] 4
[0001645460] 5
[0001645460] 8-K
[0001645460] D
[0001645460] SC 13D
[0001645460] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Bleichroeder LP Cue Biopharma Inc [2024-03-11] 6.11
BlackRock Inc Cue Biopharma Inc [2024-02-07] 4.98
BlackRock Inc Cue Biopharma Inc [2024-01-31] 5.2
Slate Path Capital LP Cue Biopharma Inc [2023-02-14] 5.6
Slate Path Capital LP Cue Biopharma Inc [2022-11-18] 5.6
BlackRock Inc Cue Biopharma Inc [2022-07-08] 2.4
State Street Corp Cue Biopharma Inc [2022-02-10] 5.23
Corriente Advisors LLC Cue Biopharma Inc [2021-02-16] 6.33
Avoro Capital Advisors LLC Cue Biopharma Inc [2020-02-14] 8.1
Nantahala Capital Management LLC Cue Biopharma Inc [2020-02-14] 6.1
BlackRock Inc Cue Biopharma Inc [2020-02-07] 6.0
Marlett Christopher A Cue Biopharma Inc [2019-12-18] 6.17
Appel Peter A Cue Biopharma Inc [2018-02-13] 7.6
Strome Mark E Cue Biopharma Inc [2018-01-09] 5.7
Form 3/4/5 Filer 2011 - 2026
Meluzio Michael Vincent
Cue Biopharma Inc
Ray Sumita
Camardo Daniel A
Lin Shao-Lee
Meehan Viola Mong
Baker Daniel G
Sandercock Colin
Warren Lucinda
Morich Frank
Kiener Peter A
Broadfoot Jill Marie
Garzone Pamela
Verheyen Patrick
Sarraf Pasha
Azam Usman
Passeri Daniel R
Millar Kerri-Ann
Levisetti Matteo
Driscoll Frederick W
Fox Michael J
Suri Anish
Nasshorn Patricia
Howson Tamar D
Fletcher Aaron GL
Gray Cameron
Pienta Kenneth
Simon Barry J
Marlett Christopher A
McKnight Steven L
Mancilla Bethany
Digiandomenico Anthony
Chaparro Rodolfo
Seidel Ronald D III
Schuman Gary Alan
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Broadfoot Jill Marie
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Morich Frank
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Garzone Pamela
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Verheyen Patrick
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Sarraf Pasha
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Kiener Peter A
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Sarraf Pasha
Common Stock
2025-12-30 Buy 77,148 $0.30 23,144
Sarraf Pasha
Common Stock
2025-12-30 Buy 77,417 $0.30 23,225
Sarraf Pasha
Common Stock
2025-12-30 Buy 86,947 $0.32 27,823
Sarraf Pasha
Common Stock
2025-12-30 Buy 4,229 $0.31 1,311
Sarraf Pasha
Common Stock
2025-12-30 Buy 78,116 $0.31 24,216
Sandercock Colin
Stock Option (right to buy) · derivative
2025-12-03 Grant 70,000 $0.00
Warren Lucinda
Stock Option (right to buy) · derivative
2025-09-29 Grant 125,000 $0.00
Baker Daniel G
Stock Option (right to buy) · derivative
2025-09-29 Grant 50,000 $0.00
Azam Usman
Stock Option (right to buy) · derivative
2025-09-29 Grant 1,875,000 $0.00
Sandercock Colin
Stock Option (right to buy) · derivative
2025-09-26 Grant 30,000 $0.00
Broadfoot Jill Marie
Stock Option (right to buy) · derivative
2025-06-04 Grant 48,800 $0.00
Millar Kerri-Ann
Stock Option (right to buy) · derivative
2025-03-21 Grant 200,000 $0.00
Passeri Daniel R
Stock Option (right to buy) · derivative
2025-03-21 Grant 450,000 $0.00
Baker Daniel G
Stock Option (right to buy) · derivative
2025-03-21 Grant 100,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 55 21,400,020
2025-12-31 48 21,788,520
2025-09-30 52 18,059,864
2025-06-30 48 17,351,745
2025-03-31 51 11,414,206
2024-12-31 57 11,782,694
2024-09-30 52 13,928,295
2024-06-30 76 13,877,184
2024-03-31 78 16,756,236
2023-12-31 81 15,171,541
2023-09-30 76 14,006,710
2023-06-30 79 13,804,876
Form 13F Holdings
Firm Period DFND Voting Shares
IFP Advisors LLC [2026-06-30] SOLE 100 100
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com